Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

India Insulin Pumps Market Growth, Share, Size, Trends, Research: By Product: Insulin Pumps, Infusion Sets, Insulin Reservoirs/Cartridges, Infusion Set Insertion Devices; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments; 2022-2027

India Insulin Pumps Market Outlook

The market size for India insulin pumps reached a value of USD 13.38 million in 2021. The India insulin pumps market is expected to grow at a CAGR of 8.7% in the forecast period of 2022-2027, to reach a value of USD 22.07 million by 2027.

 

News and Development in the market

  • In August 2022, the United States Food and Drug Administration permitted the use of Insulet tubeless insulin pumps from medical device firm Insulet Corporation for type 1 diabetic children who are of the age of 2 years or older. FDA approval is a positive sign for the India insulin pumps market, indicating possible approval for use within India as well.
  • In August 2022, the FDA approved Omnipod 5, a tubeless automated insulin delivery system to be the first to be controlled by smartphone without need for a separate controller unit. It was fully launched in early August for children aged 6 years and above.
  • In July 2022, Thiruvananthapuram-based diabetes forum ‘Jothydev’s Professional Education Forum (JPEF)’ identified that 95% of life-saving technologies including advanced patch insulin pumps, tandem etc. available in western countries were not yet available in India. These technologies, used for diabetic treatments for type 1 patients, have been highlighted for further discussion, and will likely soon enter Indian markets, driving the demand for the India insulin pumps market.
  • In March 2022, Medtronic (NYSE:MDT) India launched the MiniMed 780G system for diabetes management which is a next generation closed loop insulin pump system that is used for the treatment of type 1 diabetes for people of all ages. This system has an ability to connect to smartphones via Bluetooth, therefore allowing the patients to check their glucose level on their phones via apps.

 

Key Trends in the Market

Insulin is transferred into the body quickly with the help of a thin tube from a small, computerised device which is known as an insulin pump, to help in regulating blood sugar levels. Insulin pumps are expensive but also very accurate and precise is why they are considered more than injections, due to which there is steady growth expected for the India insulin pumps market. They are generally used by type 1 diabetic patients which are also called insulin-dependent diabetes and less commonly used by type 2 diabetic patients. An insulin pump lasts for about two to four weeks.

 

  • Reduction in the use of regular injections by replacing them with the use of insulin pumps is a key trend in the market. Accuracy provided with the insulin pumps helps in managing blood sugar levels better, allowing an individual to live a more flexible life. Also, there are fewer needle pricks through insulin pumps when compared to the injections during diabetes as instead of taking shots multiple times a day, pumps would allow to take a single shot every two to three days. Also, insulin pumps will be temporary, and one can switch to another insulin management method anytime.
  • Technological advancements in the market such as the development of insulin pumps that connect through smartphones with the help of Bluetooth are key trends. Apps are created that help individuals to continuously monitor their blood sugar levels and insulin levels wherever they are. Smarter devices are also developing continuously, driving the growth of the India insulin pumps market.
  • Insulin pumps, despite their precision are very costly and cannot be afforded by every citizen in the country. Patients in need of these pumps are in abundance and are vulnerable so they are ready to pay any price to get access to convenient modes of diabetes management. This offers opportunities to the market for lower cost insulin pumps.
  • The government is taking steps to spread awareness about these treatment methods to more and more individuals through posters, advertisements, and doctors for diabetes care. A lot of organisations, both government and private, are also travelling to rural areas and helping people know about these new developments. These methods are contributing to the growth of the India insulin pumps market.

 

Market Analysis

The India insulin pumps market by product is divided into insulin pumps, infusion sets, insulin reservoirs/cartridges, and infusion set insertion devices. Insulin pumps is further divided into traditional insulin pumps, disposable insulin pumps and others. Infusion sets are also further divided into steel cannula and plastic cannula. Based on region the market is segmented into North India, East India, West India, and South India.

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter’s five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the India n-pentane market, covering their competitive landscape and latest developments.

 

  • Medtronic MiniMed Inc.
  • F. Hoffmann-La Roche Ltd
  • AgVa Healthcare
  • Others

 

Market Share by Product

There are various types of insulin pumps available in India, with varying ranges of demand and penetration in the market. The India insulin pumps market is shared among various categories such as traditional and disposable insulin pumps, steel cannula and plastic cannula used in infusion sets, insulin reservoirs and infusion set insertion devices. All these products are interconnected and help in the working of the pumps.

 

Traditional insulin pumps run on battery and have a reservoir and insulin delivery is programmed by a simple touch or by buttons that are provided. On the other hand, disposable insulin pumps are smaller as compared to the traditional pumps. They are attached directly to the skin and contain a cannula that goes to the skin from device without tubing. Traditional insulin pumps are generally preferred by users and occupy a large share in the market. Plastic cannulas are also preferred over the steel cannula because of their biocompatibility and also plastic cannula do not pierce blood vessels and thus won’t cause severe complications unlike steel cannula.

 

Market Share by Region

In India, the demand for insulin pumps varies significantly by region, depending upon the prevalence of diabetes, general awareness, openness for new treatment modes, and spending ability. Some of the states with the highest numbers of diabetes cases are Kerala, Chandigarh, and Tamil Nadu. According to research, incidences of Type 1 diabetes are increasing at a rate of nearly 3-5 percent every year. Although type 1 diabetes is largely genetic, it can also be triggered by an auto-immune response to the environment or viruses. Insulin pumps are also commonly used by those diagnosed with Type 2 diabetes in India.

 

Southern India holds a significant section of the India insulin pumps market, with the presence of high general awareness, and growing cases of diabetes. There is greater penetration of affordable insulin pumps made in India, that are significantly lower in cost than imported alternatives. West India has been developing advanced technology pumps to be used with convenience from the comfort of their homes. There is also a strong presence of key players such as Medtronic which is located in Mumbai, Maharashtra.

 

Competitive Landscape

Medtronic MiniMed Inc. founded in 1949 is a medical device company. They develop devices used for medical purposes such as insulin pumps, CGM, and injection ports. Insulin pumps are available for any person having Type 1 or Type 2 diabetes. MiniMed 630G, and MiniMed 770G, are some insulin pumps designed by them for the India insulin pumps market to help patients with their diabetes management and manage day to day lives during their lifetime.

 

F. Hoffmann La Roche Ltd. has its headquarters in Basel, Switzerland. It is a multinational healthcare company commonly known as Roche. It has two divisions namely pharmaceutical and diagnostic. It is extensively developing innovative technologies for diabetes management such as insulin pumps that are able to monitor the blood glucose level.

 

AgVa Healthcare was founded in 2018 has its headquarters in Noida, Uttar Pradesh. It is a leader for development of medical devices and equipment with a strong position in the India insulin pumps market. It has developed India’s most advanced insulin pump ‘INSUL’ which is also highly affordable. Features of INSUL include a built-in glucometer, Bluetooth connectivity, and android and IOS app.
 

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Region
Breakup by Product
  • Insulin Pumps
  • Infusion Sets
  • Insulin Reservoirs/Cartridges
  • Infusion Set Insertion Devices
Breakup by Region
  • North India
  • East India
  • West India
  • South India
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Medtronic MiniMed, Inc.
  • F. Hoffmann-La Roche Ltd
  • AgVa Healthcare
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
7    Opportunities and Challenges in the Market
8    India Insulin Pumps Market Analysis

    8.1    Key Industry Highlights
    8.2    India Insulin Pumps Historical Market (2017-2021) 
    8.3    India Insulin Pumps Market Forecast (2022-2027)
    8.4    India Insulin Pumps Market by Product
        8.4.1    Insulin Pumps
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
            8.4.1.4.1    Traditional Insulin Pumps
            8.4.1.4.2    Disposable Insulin Pumps
            8.4.1.4.3    Others
        8.4.2    Infusion Sets
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
            8.4.2.4.1    Steel Cannula
            8.4.2.4.2    Plastic Cannula
        8.4.3    Insulin Reservoirs/Cartridges
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Infusion Set Insertion Devices
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.5    India Insulin Pumps Market by Region
            8.5.1    Market Share
            8.5.1.1    North India
            8.5.1.2    East India
            8.5.1.3    West India
            8.5.1.4    South India
9    Regional Analysis
    9.1    North India
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
    9.2    East India
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
    9.3    West India
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
    9.4    South India
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Medtronic MiniMed, Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    F. Hoffmann-La Roche Ltd
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    AgVa Healthcare
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Others
12    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    India Insulin Pumps Market: Key Industry Highlights, 2017 and 2021
2.    India Insulin Pumps Historical Market: Breakup by Product (USD Million), 2017-2021
3.    India Insulin Pumps Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    India Insulin Pumps Historical Market: Breakup by Region (USD Million), 2017-2021
5.    India Insulin Pumps Market Forecast: Breakup by Region (USD Million), 2022-2027
6.    India Insulin Pumps Market Structure
 

Key Questions Answered in the Report

The market size for India insulin pumps reached a value of USD 13.38 million in 2021.

The market size for India insulin pumps is projected to reach a value of USD 22.07 million by 2027.

The market for India insulin pumps is projected to grow at a CAGR of 8.7% between the forecast period of 2022 and 2027.

Insulin is transferred into the body quickly with the help of a thin tube from a small, computerised device which is known as an insulin pump.

Insulin pumps are expensive but are also very accurate and precise is why they are preferred more than injections.

An insulin pump lasts for about two to four weeks.

The India insulin pumps market is segmented based on product and region.

Key players in the market are Medtronic MiniMed Inc., F. Hoffmann-La Roche Ltd. and AgVa Healthcare, among others.

Major regional markets for India Insulin pumps are North India, East India, West India, and South India.

Key drivers of the market are diabetes prevalence in India, technological advancement, and increase in use of insulin pumps over traditional methods.

Relevant trends influencing the market are busy lifestyles of consumers resulting in a preference for easier diabetes management, stress levels causing fluctuations in blood sugar, and government encouragement for insulin pumps.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER